AU
UK
CA
NZ
IND
US
Last update at 2025-07-02T13:02:51.847076Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
| Income before tax | 28.54M | 42.23M | 34.77M | 25.67M |
| Minority interest | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Net income | 21.05M | 31.19M | 25.69M | 19.41M |
| Selling general administrative | 19.30M | 19.62M | 13.45M | 8.48M |
| Selling and marketing expenses | - | - | - | - |
| Gross profit | 48.68M | 61.82M | 48.82M | 35.51M |
| Reconciled depreciation | - | - | - | - |
| Ebit | 29.39M | 42.20M | 35.38M | 26.93M |
| Ebitda | - | - | - | - |
| Depreciation and amortization | - | - | - | - |
| Non operating income net other | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Operating income | 29.39M | 42.20M | 35.38M | 26.93M |
| Other operating expenses | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Interest expense | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Tax provision | - | - | - | - |
| Interest income | - | - | - | - |
| Net interest income | - | - | - | - |
| Extraordinary items | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Non recurring | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Other items | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Income tax expense | 7.49M | 11.04M | 9.09M | 6.26M |
| Total revenue | 241.87M | 257.49M | 200.81M | 136.09M |
| Total operating expenses | 212.48M | 215.29M | 165.44M | 109.16M |
| Cost of revenue | 193.18M | 195.67M | 151.99M | 100.58M |
| Total other income expense net | -0.85226M | 0.03M | -0.60238M | -1.25829M |
| Discontinued operations | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Net income from continuing ops | 21.05M | 31.19M | 25.69M | 19.41M |
| Net income applicable to common shares | 15.99M | 27.30M | 25.69M | 19.41M |
| Preferred stock and other adjustments | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Breakdown | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
| Total assets | 244.97M | 212.58M | 141.54M | 93.06M |
| Intangible assets | 13.77M | 14.09M | 14.00M | 14.64M |
| Earning assets | - | - | - | - |
| Other current assets | 10.84M | 2.46M | 1.67M | 1.65M |
| Total liab | 73.76M | 62.68M | 58.44M | 39.68M |
| Total stockholder equity | 134.27M | 116.52M | 83.10M | 53.38M |
| Deferred long term liab | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Other current liab | 2.68M | 4.41M | 4.53M | 4.31M |
| Common stock | 0.04M | 0.04M | 0.04M | 0.04M |
| Capital stock | - | - | - | - |
| Retained earnings | 105.29M | 89.30M | 62.00M | 36.31M |
| Other liab | 0.16M | 0.37M | 1.49M | 0.20M |
| Good will | 0.50M | 0.54M | 0.56M | 0.11M |
| Other assets | 8.64M | 7.74M | 4.11M | 0.66M |
| Cash | 21.61M | 31.48M | 20.16M | 13.30M |
| Cash and equivalents | - | - | - | - |
| Total current liabilities | 73.48M | 62.10M | 55.01M | 35.85M |
| Current deferred revenue | - | - | - | - |
| Net debt | - | - | - | - |
| Short term debt | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Short long term debt | 0.09M | 1.81M | 1.81M | 0.07M |
| Short long term debt total | - | - | - | - |
| Other stockholder equity | 10.03M | 8.91M | 4.43M | 2.11M |
| Property plant equipment | 22.51M | 18.10M | 14.61M | 12.17M |
| Total current assets | 199.52M | 172.09M | 108.26M | 65.48M |
| Long term investments | 0.03M | 0.03M | 0.00000M | 0.00000M |
| Net tangible assets | 120.00M | 101.89M | 68.53M | 38.63M |
| Short term investments | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Net receivables | 146.99M | 119.72M | 72.84M | 40.41M |
| Long term debt | 0.11M | 0.21M | 1.94M | 3.63M |
| Inventory | 13.60M | 14.18M | 10.78M | 8.75M |
| Accounts payable | 39.72M | 42.29M | 38.17M | 19.16M |
| Total permanent equity | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Noncontrolling interest in consolidated entity | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Temporary equity redeemable noncontrolling interests | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Accumulated other comprehensive income | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Additional paid in capital | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Common stock total equity | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Preferred stock total equity | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Retained earnings total equity | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Treasury stock | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Accumulated amortization | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Non currrent assets other | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Deferred long term asset charges | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Non current assets total | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Capital lease obligations | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Long term debt total | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Breakdown | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
| Investments | 0.00000M | -0.03136M | -0.03136M | -0.03136M |
| Change to liabilities | -2.83808M | 10.13M | 15.37M | 4.15M |
| Total cashflows from investing activities | -6.36562M | -7.44442M | -9.16945M | 1.34M |
| Net borrowings | 15.38M | -7.66954M | -2.70383M | -1.67140M |
| Total cash from financing activities | 5.93M | 22.16M | -0.52752M | 3.71M |
| Change to operating activities | -1.73315M | -2.12932M | 1.29M | -0.70131M |
| Net income | 21.05M | 31.19M | 25.69M | 19.41M |
| Change in cash | -9.87054M | 11.32M | 6.85M | 12.04M |
| Begin period cash flow | - | - | - | - |
| End period cash flow | - | - | - | - |
| Total cash from operating activities | -9.58684M | -5.12821M | 15.89M | 6.92M |
| Issuance of capital stock | - | - | - | - |
| Depreciation | 1.82M | 1.44M | 1.19M | 1.03M |
| Other cashflows from investing activities | -0.60220M | -3.36560M | -3.37910M | -3.37910M |
| Dividends paid | 1.50M | 1.50M | 1.50M | 1.50M |
| Change to inventory | 0.71M | -2.16493M | 1.27M | -2.31818M |
| Change to account receivables | -28.17884M | -44.06399M | -31.46401M | -14.42365M |
| Sale purchase of stock | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Other cashflows from financing activities | -7.94601M | -0.17362M | 0.42M | -0.94411M |
| Change to netincome | 1.50M | 0.41M | 0.61M | 0.17M |
| Capital expenditures | 5.76M | 4.07M | 0.45M | 0.07M |
| Change receivables | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Cash flows other operating | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Exchange rate changes | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Cash and cash equivalents changes | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Change in working capital | - | - | - | - |
| Stock based compensation | - | - | - | - |
| Other non cash items | - | - | - | - |
| Free cash flow | - | - | - | - |
Sector: Healthcare Industry: Pharmaceutical Retailers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to EBITDA (x) | |
|---|---|---|---|---|---|---|---|---|
| CNBI China BCT Pharmacy Group Inc |
- -% | - | - | - | 0.0014 | 0.01 | -0.184 | |
| ALBHF Alibaba Health Information Technology Limited |
- -% | 0.42 | 36.00 | 19.01 | 0.36 | 3.63 | 1.73 | 25.72 |
| RADLY Raia Drogasil SA ADR |
0.06 1.83% | 3.33 | 47.15 | 32.68 | 0.34 | 9.83 | 0.35 | 3.29 |
| ALBBY Alibaba Health Information Technology Limited |
- -% | 8.88 | 34.43 | 19.84 | 0.29 | 3.79 | 1.73 | 25.72 |
| SHPPF Shop Apotheke Europe N.V |
- -% | 64.80 | - | - | 2.80 | 2.28 | 1.70 | 78.78 |
China BCT Pharmacy Group, Inc., through its subsidiaries, operates as an integrated pharmaceutical company in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Retail Pharmacy, and Manufacturing Pharmacy. The Pharmaceutical Distribution segment purchases pharmaceutical products from suppliers and distributes them to hospitals, retail drug stores, other pharmaceutical wholesalers, clinics, medical centers, and individuals. It offers approximately 8,000 pharmaceutical and healthcare products, including branded and generic prescription medicines, over-the counter medicines, and Western and Chinese medicines, as well as personal care products and medical supplies, Chinese herbs, and medical instruments. The Retail Pharmacy segment operates a retail pharmacy network of 196 directly owned stores, primarily in Guangxi province under the Baicaotang name. The retail stores provide professional pharmaceutical services, and supply various medicines, such as prescription medicines, over-the-counter medicines, Chinese herbal medicine, roughly processed Chinese herbal medicine, family planning products, and other pharmaceutical and healthcare products. The Manufacturing Pharmacy segment manufactures and sells generic and clinic drugs, such as traditional anti-inflammatory and antibacterial drugs, cancer treatment drugs, cardio-vascular disease drugs, and hepatitis drugs under the Asio name. Its products comprise Levodopa, Tabellae Sarcandrae, Rotandine Sulfate, Corydalis Saxicola Bunting, and Ethacridine Lactate injection. The company was formerly known as China Baicaotang Medicine Limited and changed its name to China BCT Pharmacy Group, Inc. in March 2010. China BCT Pharmacy Group, Inc. was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.
No. 102, Chengzhan Road, Liuzhou, China, 545007
| Name | Title | Year Born |
|---|---|---|
| Mr. Huitian Tang | Chairman and Chief Exec. Officer | 1962 |
| Ms. Xiaoyan Zhang | Chief Financial Officer, Principal Accounting Officer, Sec. and Director | 1973 |
| Mr. Huitian Tang | Chairman of the Board and Chief Executive Officer | 1962 |
| Ms. Xiaoyan Zhang | Chief Financial Officer, Principal Accounting Officer, Secretary and Director | 1973 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...